TP53 and cervical cancer: This study designed novel pyrrolidine-chalcone derivatives targeting the MDM2-p53 interaction.<h4>Methods</h4>A series of compounds were synthesized and evaluated for cytotoxicity against cervical cancer (HeLa, SiHa, C33A) and normal (H8) cells via CCK-8.